Connecting the Lab to Everyday Life: The Relevance of Executive Dysfunction to Participation and Quality of Life in Parkinson's Disease (PD) Without Dementia
NCT ID: NCT00917280
Last Updated: 2015-06-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
174 participants
OBSERVATIONAL
2008-12-31
2014-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Self-Reports of Executive Functions in Persons With Parkinson's Disease and Their Significant Others
NCT04928027
Development of a Face Valid Executive Functioning Task
NCT00918112
Rehabilitation of Everyday Memory Impairment in Parkinson Disease: A Pilot Study
NCT01469741
Prospective Memory Training in Parkinson Disease
NCT03582670
Multicontext Approach for Cognitive Function in Parkinson Disease
NCT07190404
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Parkinson's Disease
Parkinson Disease participants without dementia
No interventions assigned to this group
Control
Non-PD participants, matched for age, education and gender.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* males or females between 40 and 70
* meet criteria for idiopathic typical PD
* classified at Hoehn \& Yahr12 stage I, II, or III
* are currently treated with levodopa/carbidopa
* The groups will be matched for age, education and gender
* No Parkinson Disease
Exclusion Criteria
* treatment with certain dopaminergic, anticholinergic or benzodiazepine medications
* other neurological problems
* brain surgery
* history or current psychotic disorder
* any condition which would interfere with testing
* control only: a biological family history of PD and being a caregiver or spouse of someone who has PD
40 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Washington University School of Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Erin Foster
Assistant Professor of Occupational Therapy, Neurology and Psychiatry
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Erin Foster
Role: PRINCIPAL_INVESTIGATOR
Washington University School of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Washington University School of Medicine
St Louis, Missouri, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
#E07-117
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.